SCHEMBL111408

SCHEMBL111408

CC(CO)CCCC1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.48
MAPT P10636 2/20 0.44
SIGMAR1 Q99720 3/20 0.41
TSHR P16473 1/20 0.38
METAP1 P53582 1/20 0.38
OPRK1 P41145 1/20 0.35
BMP1 P13497 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30754374 1.00 CYP1A2 (0.48) CYP1A2MAPTSIGMAR1TSHRMETAP1
Alcohol SCHEMBL17544758 0.96 CYP1A2 (0.50) CYP1A2MAPTSIGMAR1TSHRMETAP1
SCHEMBL29102100 0.88 METAP1 (0.44) CYP1A2SIGMAR1TSHRMETAP1
SCHEMBL4761964 0.82 MAPT (0.46) MAPTTSHR
SCHEMBL4761969 0.82 CYP1A2 (0.47) CYP1A2MAPTSIGMAR1METAP1OPRK1
SCHEMBL5148322 0.82 CYP1A2 (0.56) CYP1A2MAPTSIGMAR1METAP1OPRK1
SCHEMBL6933779 0.82 CYP1A2 (0.50) CYP1A2MAPTSIGMAR1METAP1OPRK1
SCHEMBL25493249 0.81 MAPT (0.41) MAPTTSHR
SCHEMBL113022 0.81 MAPT (0.45) MAPTTSHR
SCHEMBL18176007 0.80 ALDH1A1 (0.35) CYP1A2MAPTSIGMAR1TSHRMETAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 321 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743053-A1 ANTIMICROBIAL SYNERGIES Symrise AG (DE) 2026-05-20 EP claimed
EP-4743051-A1 3-HYDROXYPROPYLESTERS AS SOLUBILITY ENHANCERS FOR LIPOPHILIC INGREDIENTS Symrise AG (DE) 2026-05-20 EP claimed
EP-4554551-B1 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS SYMRISE AG (DE) 2026-03-11 EP claimed
US-20260041094-A1 Compositions Comprising an Antimicrobial Boosting Agent SYMRISE AG (DE) 2026-02-12 US claimed
EP-4616840-A2 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION Symrise AG (DE) 2025-09-17 EP claimed
US-20250270182-A1 Composition Comprising an Antimicrobial Agent and an Alkyl Ketal Ester Compound SYMRISE AG (DE) 2025-08-28 US claimed
US-20250268813-A1 ANTIPERSPIRANT/DEODORANT COMPOSITIONS REVLON CONSUMER PRODUCTS CORPORATION 2025-08-28 US claimed
EP-4103288-B1 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION SYMRISE AG (DE) 2025-07-30 EP claimed
EP-4582079-A2 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION Symrise AG (DE) 2025-07-09 EP claimed
EP-4565191-A1 COMPOSITION COMPRISING A UV-FILTER STABILIZER Symrise AG (DE) 2025-06-11 EP claimed
EP-3877494-A1 AN ANTIMICROBIAL SURFACTANT BASED COMPOSITION Symrise AG (DE) 2021-09-15 EP claimed
CN-111683651-A Cosmetic ink composition comprising surface tension regulator 宝洁公司 2020-09-18 CN claimed
US-10722437-B2 Cosmetic agents with “improved protection against body odor” HENKEL AG & CO. KGAA (DE) 2020-07-28 US claimed
EP-3500236-A1 A PRESERVATIVE MIXTURE Symrise AG (DE) 2019-06-26 EP claimed
EP-3398584-A1 COSMETIC COMPOSITIONS COMPRISING A SYNERGISTIC COMBINATION OF PERSPIRATION-ABSORVING AND PERSPIRATION-ADSORBING PARTICLES, AND USE THEREOF Natura Cosméticos S.A. (BR) 2018-11-07 EP claimed
WO-2018036625-A1 A PRESERVATIVE MIXTURE SYMRISE AG (DE) 2018-03-01 WO claimed
US-20170189289-A1 COSMETIC COMPOSITIONS COMPRISING A SYNERGISTIC COMBINATION OF SWEAT ABSORBING PARTICLES AND ADSORBING PARTICLES AND USE THEREOF Natura Cosméticos S.A. (BR) 2017-07-06 US claimed
US-20150328099-A1 Antitranspirant Deodorant Cosmetic Composition Having Dermo-Calming Action NATURA COSMÉTICOS S.A (BR) 2015-11-19 US claimed
WO-2014110035-A1 ODOR SUPPRESSION OF VOLATILE ORGANIC ANALGESIC COMPOUNDS AND METHOD OF USE CHATTEM, INC. (US) 2014-07-17 WO claimed
US-8697043-B1 Odor suppression of volatile organic analgesic compounds and method of use CHATTEM, INC. (US) 2014-04-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270182-A1 Composition Comprising an Antimicrobial Agent and an Alkyl Ketal Ester Compound GK, DAGLA, KAT5 CYP1A2 3445/4885MAPT 4222/4885SIGMAR1 2248/4885
US-20260041094-A1 Compositions Comprising an Antimicrobial Boosting Agent TLR7, MYC, ERG28 CYP1A2 3018/4885MAPT 4723/4885SIGMAR1 818/4885
US-10722437-B2 Cosmetic agents with “improved protection against body odor” DAGLA, MGLL, CRAT CYP1A2 1665/4885MAPT 760/4885SIGMAR1 436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.